Publicaciones en colaboración con investigadores/as de Hospital de Cruces (15)

2024

  1. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

2023

  1. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  2. Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography

    Life, Vol. 13, Núm. 3

  3. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

    Life, Vol. 12, Núm. 12

2021

  1. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

    PLoS ONE, Vol. 15, Núm. 3

  2. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study

    Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718

2019

  1. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence

    International Journal of Medical Sciences, Vol. 16, Núm. 6, pp. 813-821

  2. Imaging Mass Spectrometry–Based Lipidomic Approach to Classification of Architectural Features in Nevi

    Journal of Investigative Dermatology, Vol. 139, Núm. 9, pp. 2055-2058.e7

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

  2. Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms

    Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267

2010

  1. Histamine and histamine receptor antagonists in cancer biology

    Inflammation and Allergy - Drug Targets, Vol. 9, Núm. 3, pp. 146-157

2009

  1. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

    British Journal of Dermatology, Vol. 160, Núm. 3, pp. 519-526

2006

  1. H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells

    Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796